New T-cell engager therapy shows effectiveness in advanced solid tumors
View as a Web Page
News Medical
 
  Hematology Hematology logo  
  The latest hematology news from News Medical  
 AI maps how brain fluids move to clear wasteAI maps how brain fluids move to clear waste
 
MR-AIV uses physics-informed AI and DCE-MRI scans to infer 3D brain-wide fluid movement in mice without direct flow measurements. The method distinguished slow diffusion-dominated transport from faster advective flow and estimated pressure and permeability patterns linked to brain waste clearance.
 
 
 New T-cell engager therapy shows effectiveness in advanced solid tumorsNew T-cell engager therapy shows effectiveness in advanced solid tumors
 
A team led by researchers from the National Center for Tumor Diseases (NCT/UCC) Dresden at the Carl Gustav Carus University Hospital (UKD) and the Carl Gustav Carus Faculty of Medicine at the TUD Dresden University of Technology will present clinical results for the first time on May 31, 2026, at this year’s annual meeting of the American Society of Clinical Oncology (ASCO) regarding a new cancer immunotherapy for the treatment of advanced tumors.
 
   Vaginal bromocriptine may ease pain and heavy bleeding in adenomyosisVaginal bromocriptine may ease pain and heavy bleeding in adenomyosis
 
A pilot randomized controlled trial found that vaginal bromocriptine reduced menstrual bleeding, pelvic pain, menstrual duration, and cycle irregularity in women with adenomyosis compared with routine treatment.
 
   Common anemia drugs may help slow cancer growth and progressionCommon anemia drugs may help slow cancer growth and progression
 
Common medications used to treat anemia may also slow down cancer cell growth, according to new research from Finland.
 
   Could guava juice help prevent anemia?Could guava juice help prevent anemia?
 
Guava juice intake is linked to increased hemoglobin levels in females, highlighting its role as a dietary complement to traditional iron supplementation.
 
 First-in-class cancer drug gamitrinib evaluated in phase 1 clinical trial
 
First-in-class cancer drug gamitrinib evaluated in phase 1 clinical trialCancer cells need large amounts of energy to survive and multiply. To produce that energy, they rely on structures inside the cell called mitochondria, often described as the cell's "powerhouse."
 
 
 Next-Generation CRISPR Tools Transform Gene Editing And Gene Therapy
 
Next-Generation CRISPR Tools Transform Gene Editing And Gene TherapyEmerging gene editing platforms are revolutionizing precision medicine, enabling safe and effective genetic modifications for diverse therapeutic applications.
 
 
 New study frames altered protein modifications as cancer drivers
 
New study frames altered protein modifications as cancer driversCancer has often been explained through mutations in deoxyribonucleic acid (DNA) or changes in ribonucleic acid (RNA), but these layers do not fully explain why tumors with similar genetic profiles can behave differently.
 
 
 Study finds serious blood-related side effects associated with antibody-drug conjugates
 
Study finds serious blood-related side effects associated with antibody-drug conjugatesA major real-world study by University of California, Irvine pharmacy researchers has found serious blood-related side effects associated with antibody-drug conjugates, an increasingly important class of targeted cancer therapies.
 
 
 CAR-T cell therapy shows promise for treating rheumatoid arthritis
 
Current therapies for rheumatoid arthritis rely on sustained immunosuppression rather than restoration of immune tolerance, with off-drug remission remaining rare.
 
 
 New PET radiotracer shows high accuracy for detecting clots in the legs and lungs
 
A novel PET radiotracer can accurately detect deep vein thrombosis in the legs and reveal whether clots have migrated to the lungs.
 
 
 Genetically-modified hookworms successfully deliver medicine to animal hosts
 
Hookworms, intestinal parasites that infect hundreds of millions of people in under-resourced tropical regions around the globe, have evolved to survive inside the human gut for years, secreting molecules that enable co-existence with their hosts.
 
 
 New SMArT platform improves safety of CRISPR gene editing
 
A team of researchers led by Luigi Naldini at the San Raffaele Telethon Institute for Gene Therapy (SR-Tiget) has developed a new strategy to significantly improve the precision and safety of CRISPR-Cas9 gene editing in human blood stem cells, potentially overcoming one of the major barriers limiting broader clinical application of genome editing therapies.
 
 
 Stem cell transplantation is the most cost-effective sickle cell treatment
 
Stem cell transplantation is the most cost-effective option for long-term care of sickle cell disease in adults when compared with gene therapy and standard of care treatment, according to new research published in Blood.
 
 
 New all-oral regimen improves treatment convenience for AML patients
 
The ASCERTAIN V clinical trial demonstrated that an all-oral drug combination for older patients with acute myeloid leukemia (AML) is an effective alternative to the current standard, which requires repeated hospital or office visits for intravenous treatment.
 
 
 Novel PRRT approach shows promise in advanced neuroendocrine tumors
 
A new type of peptide receptor radionuclide therapy (PRRT) appears to be safe in metastatic neuroendocrine tumor patients who have exhausted conventional treatment options.
 
 
 Online resources on AI and cancer lack quality, need improvement
 
Online information about artificial intelligence (AI) and its impact on cancer research and treatment for both the patient and general-public audiences is limited, and the available webpages and videos are largely of low quality, difficult to read, and frequently omit risks of AI use, according to new research presented today at the at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting (Abstract 9000) and led by researchers from...
 
 
 Study reveals how germinal centers consistently produce antibodies
 
A new study tracking thousands of B cells across more than 100 germinal centers in mice reveals how the system consistently produces highly effective antibodies.
 
 
 City of Hope sets new standard for lifelong, research-driven cancer survivorship care
 
Supporting the growing number of Americans living with cancer has become one of the most urgent challenges in modern cancer care as more people live years or decades beyond a diagnosis.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026